Effects and mechanisms of dexmedetomidine preconditioning on isoproterenol-induced ventricular arrhythmias Authors: Shengji Duan, Xueru Liu, Jianhong Li, Yangpeng Li, Tangting Chen, Shuzhi Zhou Published: 2024 ABSTRACT Dexmedetomidine (DEX) is commonly used in clinical practice because of its sedative, analgesic, antisympathetic, hemodynamic stabilization and antianxiety effects. Previous clinical studies have demonstrated that DEX plays a role in both the prevention and treatment of perioperative arrhythmias. However, the precise mechanisms underlying the effects of DEX remain unclear. Furthermore, few studies have examined the effect of DEX on cardiac electrophysiology. ECG recording was performed in vivo and ex vivo on C57 mice. Simultaneous recording of membrane voltage (Vm) and [Ca2+]i changes was achieved with dual-dye optical mapping, in which voltage- and Ca2+-sensitive dyes are employed. Simultaneous programmed electrical stimulation was used to pacing and induce arrhythmias. Simulating catecholamine-induced arrhythmias with isoprotereno (ISO) and preconditioning with DEX to investigate the antiarrhythmic effects of DEX. Our findings demonstrated that ISO increased the incidence of ventricular tachycardia or ventricular fibrillation in mice during rapid pacing stimulation. DEX preconditioning reduced the incidence of ISO-induced ventricular arrhythmias. Optical mapping with simultaneous recordings of dual dyes (Vm dye and intracellular Ca2+ dye) revealed that DEX pretreatment attenuated the ISO-induced shortening of action potential duration (APD), calcium transient duration (CaTD), and time-to-peak (TTP) of calcium transients, as well as the ISO-induced increase in repolarization heterogeneity. DEX also slowed the conduction velocity. More importantly, DEX preconditioning significantly reduced the calcium transient alternans ratio at 80-ms, 70-ms, and 60-ms pacing cycles. These findings suggest that DEX preconditioning can reduce the incidence of ventricular arrhythmias induced by acute stress simulated by ISO. Prolongation of action potential duration and calcium transient duration and the maintenance of intracellular calcium homeostasis may be the electrophysiological mechanisms involved.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-024-79236-y. Introduction Cardiovascular adverse events are a leading cause of perioperative mortality in patients undergoing general anesthesia, with ventricular arrhythmia being one of the most significant high-risk events1. The increased risk of adverse cardiovascular events, such as ventricular arrhythmias during surgery, could be attributed to the excessive secretion of catecholamines induced by perioperative stress2,3. Therefore, suppressing perioperative stress and reducing the occurrence of arrhythmias can increase perioperative patient safety. The study of the effects of different anesthetic techniques and drugs on perioperative stress in patients has become a significant focus for clinical anesthesiologists in recent years. Dexmedetomidine (DEX) is a highly selective α2-adrenergic receptor (α2-AR) agonist, which is extensively utilized for sedation and analgesia in anesthesiology and intensive care unit (ICU). DEX induces a decrease in catecholamine secretion through both central and peripheral effects, thereby inhibiting the stress response4. Notably, DEX has been observed to exert an anti-ventricular arrhythmic effect in cardiovascular surgery5,6. However, the mechanisms underlying the antiarrhythmic effects of DEX have not yet been clarified. Abnormal calcium regulation can contribute to arrhythmias through various mechanisms, including the promotion of triggered activity, the modulation of ion channels, and structural remodeling of the heart7. Correcting abnormal calcium activity in cardiomyocytes and addressing calcium homeostatic imbalances are also important targets for intervention in the management of different types of arrhythmias8–10. However, the effect of DEX on intracellular calcium regulation in cardiomyocytes is unknown. In this study, we investigate the inhibitory effects of DEX on the ventricular arrhythmias induced by acute stress. We conducted in vitro and ex vivo experiments to study the effect of DEX on myocardial electrophysiological function using an optical labeling technique. Additionally, we aimed to investigate the cardiac antiarrhythmic mechanism of DEX . Methods Animals C57/BL mice aged 8–16 weeks, male or female, weighing 20–25 g, were provided by the Laboratory Animal Center of Southwest Medical University. Mice were fed and managed in accordance with the “Measures for the Quality Management of Laboratory Animals”. The mice were housed under specific pathogen-free conditions with a 12-hour light/dark cycle, were provided with food and water ad libitum, and were maintained at a temperature of 22℃ and a humidity level of 55%. This study protocol was approved by the Guidelines for the Care and Use of Medical Laboratory Animals of China. The animal experiment was approved by Animal Ethics Committee of Southwest Medical University (NO. 20220812-026). The study was conducted in accordance with ARRIVE guidelines. Electrocardiogram/programmed electrical stimulation (PES) Mice were randomly divided into 2 groups, the dexmedetomidine group (DEX group, n = 23) and the control group (Con group, n = 23). All the mice were terminally anaesthetized with 1-1.5% isoflurane using a gas anesthesia machine (RWD Life Science, Shenzhen City, Guangdong Province, China). The body surface ECGs of the mice were monitored and recorded via an MP 150 (BIOPAC Systems Inc, USA) multichannel physiological instrument. To induce ventricular arrhythmias, PES was administered to anesthetized mice. The mouse heart was exposed, and stimulating electrodes (SEN-7203, NIHON KOHDEN, Japan) were placed on the surface of the heart and connected to the stimulator. The mice received 30 pacing bursts pacing with a cycle length of 30 ms, which was repeated 5 times to induce ventricular arrhythmias. Ventricular arrhythmias are defined as ventricular tachycardia (VT) and ventricular fibrillation (VF): VT is defined as the presence of three or more consecutive ventricular preterm systolic contractions with a regular waveform, and VF is characterized by an irregular fibrillation waveform. After the baseline was recorded, intraperitoneal injections of 25 µg/kg DEX or saline treatment were given. Fifteen minutes later, both groups were subjected to acute stress via intraperitoneal injections of isoprenaline (ISO) (1 mg/kg) (Fig. 1 protocol in vivo). Langendorff-perfused isolated hearts After intraperitoneal injection of heparin sodium (200 U) and heparinization for 15 min, the mice were anesthetized with 5% isoflurane, euthanized by cervical dislocation. Then, the mice’s chests were opened, and the hearts were removed and rapidly placed in 4 °C PSS solution. Aortic perfusion of the mice hearts were conducted at 68–74 mmHg (1–2 ml/min) at 37 °C using Langendorff apparatus. The isolated hearts of the mice were randomly divided into 2 groups, the DEX group (n = 10) and the Con group (n = 10), and were perfused with 2 µM DEX or saline, respectively. Both group of hearts were simulated to be acutely stressed by perfusion with 1 mg/kg ISO after 15 min (Fig. 1 protocol ex vivo). Fig. 1Protocol. (in vivo, in vivo experiment; ex vivo, ex vivo experiment; PES, programmed electrical stimulation; NS, saline; DEX, dexmedetomidine; ISO, isoprenaline). Protocol. (in vivo, in vivo experiment; ex vivo, ex vivo experiment; PES, programmed electrical stimulation; NS, saline; DEX, dexmedetomidine; ISO, isoprenaline). Ex vivo heart preparations for optical mapping The excitatory contraction uncoupling agent blebbistatin (Tocris Bioscience, Minneapolis, MN, USA) was used to stop the heart to eliminate artifacts caused by heartbeats during optical signal acquisition. The heart was transferred to a specialized chamber containing Krebs solution with 10 µM blebbistatin. The Ca2+ dye Rhod-2AM (Thermo Fisher Scientific, USA) was administered as a 20 µl bolus over a 5-min period using a stock solution of 1 mg/ml in dimethylsulfoxide. Additionally, the voltage-sensitive dye RH237 (Thermo Fisher Scientific, USA) was loaded with a 30 µl bolus of 1 mM concentration. Optical mapping was performed with an upright microscope equipped with a high-speed EMCCD (Evolve 512, Photometrics, Tucson, AZ, USA) camera. Excitation light was provided by a four-light-emitting diode MacroLED lamp (530 nm, Cairn Research). Vm data were collected with a 630 nm long-pass filter, whereas Ca2+ fluorescence data were collected with a 585/40 nm bandpass filter. Data were acquired at a rate of 1000 frames/s in a 512 × 512 pixel grid. During the experiment, the hearts were subjected to apical pacing with a CL of 100 ms (10 Hz). To induce ventricular arrhythmias, the hearts were paced with a CL of 20 ms, with 30 bursts, which was repeated 5 times. During the experiment, ECGs were monitored by Spike2 (Cambridge Electronic Design Limited, UK). The recorded images were decoded and analyzed via ElectroMap Birmingham 2018 as well as OMapScope 5.0 software. Statistical analysis The data were organized, statistically analyzed with GraphPad Prism 8.0 and expressed as the mean ± SEM. Statistical significance was usually determined by Student’s t test (calcium transient alternans ratio) and two-way ANOVA with post-hoc Sidak test [heart rate, action potential duration at 50% repolarization (APD 50), action potential duration at 80% repolarization (APD80), APD80 heterogeneity, calcium transient duration 50% repolarization (CaTD50), calcium transient duration 80% repolarization (CaTD80), CaTD80 heterogeneity, calcium transient time to peak (TTP), conduction velocity], the χ2 test or Fisher’s exact probability method (incidence of ventricular arrhythmias and spatially discordant alternans). The Shapiro-Wilk test confirmed the normality of the data. P < 0.05 indicated a significant difference. Results Anti-ventricular arrhythmia effect of DEX pretreatment The surface ECG results indicated that DEX effectively slowed the heart rate. The DEX hearts exhibited a reduction in heart rate in comparison to the NS hearts (368.0 ± 23.24 bpm vs. 438.2 ± 22.95 bpm, P < 0.001), and similarly, the DEX + ISO hearts demonstrated a notable decrease in heart rate relative to the ISO + NS hearts (420.7 ± 20.85 bpm vs. 503.0 ± 24.23 bpm, P < 0.001, Fig. 2A and B). To evaluate the impact of DEX preconditioning on the incidence of stress-induced ventricular arrhythmias, programmed electrical stimulation was conducted in vivo. The findings revealed that the incidence of ventricular tachycardia (VT) or ventricular fibrillation (VF) (Fig. 2C) was significantly greater in NS + ISO hearts following ISO injection (8.7% vs. 52.2%, P < 0.01), which simulated acute stress. In contrast, DEX pretreatment DEX + ISO hearts significantly decreased the occurrence of ISO-induced VT compare with NS + ISO hearts (17.4% vs. 52.2%, P < 0.05, Fig. 2D). Similar outcomes were observed in vitro, where Langendorff isolated heart perfusion demonstrated that DEX preconditioning DEX + ISO hearts reduced the incidence of ISO-induced VT in Langendorff-perfused mouse hearts compare with NS + ISO hearts (10% vs. 70%, P < 0.01, Fig. 2E and F). These results suggest that DEX preconditioning may play a role in mitigating the incidence of stress-induced ventricular arrhythmias. Fig. 2DEX preconditioning reduces the incidence of ventricular arrhythmias induced by isoprenaline-mimicking stress in mice. (A) Typical surface of the body of the heart of a mouse after the administration of DEX and ISO. (B) Statistical comparison of heart rate at different times in the two groups of mice (n = 23). (C) A typical ECG example of ventricular arrhythmias induced after ISO treatment in conjunction with rapid pacing at the in vivo level, as well as the inhibitory effect of DEX reconditioning on these ventricular arrhythmias. (D) Statistical comparison of the incidence of ventricular arrhythmias in both groups of mice in vivo (n = 23). (E) Ex vivo heart models were constructed for the perfusion of isolated Langendorff mouse hearts. Ventricular arrhythmia was induced by rapid pacing after acute stress treatment with ISO in the Con group, but sinus rhythm was restored in the DEX group. Typical ECG examples. (F) Statistical comparison of the incidence of ventricular arrhythmias in the two groups of mice at the isolation level (n = 10). (*P < 0.05, **P < 0.01, ***P < 0.001; PCL, pacing cycle length.). DEX preconditioning reduces the incidence of ventricular arrhythmias induced by isoprenaline-mimicking stress in mice. (A) Typical surface of the body of the heart of a mouse after the administration of DEX and ISO. (B) Statistical comparison of heart rate at different times in the two groups of mice (n = 23). (C) A typical ECG example of ventricular arrhythmias induced after ISO treatment in conjunction with rapid pacing at the in vivo level, as well as the inhibitory effect of DEX reconditioning on these ventricular arrhythmias. (D) Statistical comparison of the incidence of ventricular arrhythmias in both groups of mice in vivo (n = 23). (E) Ex vivo heart models were constructed for the perfusion of isolated Langendorff mouse hearts. Ventricular arrhythmia was induced by rapid pacing after acute stress treatment with ISO in the Con group, but sinus rhythm was restored in the DEX group. Typical ECG examples. (F) Statistical comparison of the incidence of ventricular arrhythmias in the two groups of mice at the isolation level (n = 10). (*P < 0.05, **P < 0.01, ***P < 0.001; PCL, pacing cycle length.). Effect of DEX on action potential duration (APD) The effect of DEX on action potential duration (APD) in the Langendorff-perfused hearts of mice was investigated with optical mapping techniques (Fig. 3A). First, Fig. 3B shows a representative heatmap of APD80, and Fig. 3C shows how the action potential time scale is calculated. The results indicated that ISO significantly shortened both the APD50 (21.26 ± 2.62 ms vs. 24.99 ± 3.60 ms, P < 0.001) and APD80 when compared to NS hearts (26.86 ± 4.16 ms vs. 34.87 ± 5.16 ms, P < 0.001). Conversely, DEX prolonged APD50 (29.29 ± 5.05 ms vs. 25.5 ± 3.92 ms, P < 0.01) and APD80 (41.37 ± 7.29 ms vs. 33.48 ± 10.18 ms, P < 0.01) when compared to baseline hearts (Fig. 3D and E). Additionally, the APD50 and APD80 of DEX + ISO hearts were significantly longer than those of NS + ISO hearts following ISO injection (P < 0.05 for both). Furthermore, NS + ISO hearts exhibited increased APD80 heterogeneity compared to NS hearts (0.99 ± 0.24 vs. 0.76 ± 0.29, P < 0.001, Fig. 3F), an effect that was mitigated by DEX preconditioning in DEX + ISO hearts compared to NS + ISO hearts (0.68 ± 0.21 vs. 0.99 ± 0.24, P < 0.01). Collectively, these findings suggest that DEX preconditioning not only prolongs APD but also attenuates the ISO-induced increase in APD heterogeneity. Fig. 3Effect of DEX on APD. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of APD80 in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Action potential waveform and schematic of the APD measurement method. (D) Statistical plots of the APD50 at different time points in the two groups of mice. (E) APD80. (F) Heterogeneity in APD80. (n = 10; *P < 0.05, **P < 0.01, ***P < 0.001). Effect of DEX on APD. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of APD80 in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Action potential waveform and schematic of the APD measurement method. (D) Statistical plots of the APD50 at different time points in the two groups of mice. (E) APD80. (F) Heterogeneity in APD80. (n = 10; *P < 0.05, **P < 0.01, ***P < 0.001). Effect of DEX on calcium transient duration (CaTD) Using optical mapping techniques, we simultaneously recorded the effects of DEX on CaTD in Langendorff-perfused mouse hearts (Fig. 4A). CaTD was assessed during ventricular electrical stimulation with a pacing cycle length (PCL) of 100 ms. A heatmap of CaTD80 is shown in Fig. 4B, and a schematic of the calcium transient duration measurement method is shown in Fig. 4C. The results indicated that ISO decreased both the CaTD50 (26.51 ± 5.05 ms vs. 35.03 ± 4.98 ms, P < 0.001) and CaTD80 when compared to NS hearts (40.38 ± 5.57 ms vs. 53.21 ± 4.98 ms, P < 0.001). In contrast, DEX preconditioning prolonged CaTD50 (34.16 ± 7.68 ms vs. 26.51 ± 5.05 ms, P < 0.05) and CaTD80 when compared to baseline hearts (48.87 ± 8.12 ms vs. 40.38 ± 5.57 ms, P < 0.05) (Fig. 4D and E). TTP100 and TTP50 refer to the time between the baseline level of the intracellular calcium transient and the halfway point between the peak of the ascending branch and the apex of the heart, reflecting the dramatic rate of increase in the intracellular calcium concentration. ISO shortened TTP100 (12.48 ± 2.24 ms vs. 15.83 ± 3.04 ms, P < 0.001) and TTP50 compare with NS hearts (6.62 ± 1.52 ms vs. 8.66 ± 1.72 ms, P < 0.001), whereas DEX preconditioning significantly prolonged both TTP100 (17.24 ± 2.95 ms vs. 12.48 ± 2.24 ms, P < 0.001, Fig. 4G) and TTP50 when compared to baseline hearts (8.00 ± 1.22 ms vs. 6.62 ± 1.52 ms, P < 0.05, Fig. 4H). Additionally, ISO increased the heterogeneity of CaTD80 when compared to NS hearts (0.37 ± 0.07 vs. 0.31 ± 0.05, P < 0.001), an effect that was mitigated by DEX preconditioning in DEX + ISO hearts compared to NS + ISO hearts (0.31 ± 0.02 vs. 0.37 ± 0.07, P < 0.05, Fig. 4F). In conclusion, DEX preconditioning prolonged CaTD and TTP while also attenuating the ISO-induced increase in CaTD heterogeneity. Fig. 4Effect of DEX on CaTD. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of CaTD80 in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Calcium transient waveform and schematic of the calcium transient duration measurement method. (D, E, F, G, H) Statistical plots of CaTD50, CaTD80, CaTD80 heterogeneity, and TTP100 and TTP50 at different time points in the two groups of mice. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001). Effect of DEX on CaTD. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of CaTD80 in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Calcium transient waveform and schematic of the calcium transient duration measurement method. (D, E, F, G, H) Statistical plots of CaTD50, CaTD80, CaTD80 heterogeneity, and TTP100 and TTP50 at different time points in the two groups of mice. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001). Effect of DEX on calcium transient alternans Calcium transient alternations were induced via the programmed electrical stimulation S1S1 protocol. Figure 5A displays a typical heatmap of calcium transients induced by a PCL with pacing frequencies of 60 ms and 70 ms, along with the corresponding waveforms. Figure 5B shows the calculation of the calcium transient alternans ratio (CaT alternans ratio): CaT alternans ratio = 1 - (smaller calcium transient amplitude ÷ larger calcium transient amplitude). Our results showed that the calcium transient alternation ratio was significantly increased by ISO with increasing pacing frequency, but DEX significantly decreased the calcium transient alternation ratio at pacing frequencies of 80 ms (0.05 ± 0.01 vs. 0.16 ± 0.02, P < 0.01), 70 ms (0.17 ± 0.06 vs. 0.32 ± 0.04, P < 0.001), and 60 ms (0.34 ± 0.06 vs. 0.45 ± 0.09, P < 0.01, Fig. 5C). Fig. 5DEX alleviates calcium transient alternation. (A) Representative heatmaps of calcium transient alternations at various time points in the two groups induced by a gradual decrease in the length of the pacing cycle through electrical stimulation, along with the corresponding waveforms of calcium transient alterations in the labeled regions on the heatmaps. (B) Calculation of the calcium transient alternans ratio. (C) Statistical plots of the mean values of the calcium transient alternation ratio for both groups at different pacing frequencies at different time points. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001, DEX + ISO vs. NS + ISO). DEX alleviates calcium transient alternation. (A) Representative heatmaps of calcium transient alternations at various time points in the two groups induced by a gradual decrease in the length of the pacing cycle through electrical stimulation, along with the corresponding waveforms of calcium transient alterations in the labeled regions on the heatmaps. (B) Calculation of the calcium transient alternans ratio. (C) Statistical plots of the mean values of the calcium transient alternation ratio for both groups at different pacing frequencies at different time points. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001, DEX + ISO vs. NS + ISO). Following the administration of ISO, calcium transient alternans may exhibit spatial inhomogeneity, specifically known as spatially discordant alternans (SDA), at a pacing cycle length (PCL) of 60 ms (Fig. 6B). In one region of the heart, there is a consistent variation in the amplitude of the calcium transient, alternating between large and small. Moreover, in another region of the heart, the calcium transient exhibits the opposite pattern, alternating between small and large transients. A representative heatmap of spatially concordant alternans (SCA) is shown in Fig. 6A. Con group mice demonstrated a notable increase in spatially discordant alternans after receiving ISO treatment. Although there was no statistically significant difference in the occurrence of spatially discordant alternans between the groups, the incidence of these alternations tended to decrease after pretreatment with DEX (Fig. 6C). Fig. 6Effects of DEX on spatially discordant calcium transient alternans. (A) Representative heatmap spatially concordant alternans (SCA) and the corresponding calcium transient alternans waveforms for the regions labeled in the heatmap. (B) Spatially discordant alternans (SDA). (C) Statistical results for the incidence of spatially discordant alternans. (n = 10). Effects of DEX on spatially discordant calcium transient alternans. (A) Representative heatmap spatially concordant alternans (SCA) and the corresponding calcium transient alternans waveforms for the regions labeled in the heatmap. (B) Spatially discordant alternans (SDA). (C) Statistical results for the incidence of spatially discordant alternans. (n = 10). Effect of DEX on conduction velocity The impact of DEX on conduction velocity in the hearts of Langendorff-perfused mice was examined with an optical mapping technique (Fig. 7A). Conduction velocity was assessed while ventricular electrical stimulation pacing was applied (with a pacing cycle length (PCL) of 100 ms) (Fig. 7B). The results indicate that, compared with baseline hearts, DEX decreased the conduction velocity (67.53 ± 7.17 cm/s vs. 75.1 ± 7.84 cm/s, P = 0.001, Fig. 7C), whereas ISO led to an increase in the conduction velocity when compared to NS hearts (85.73 ± 7.1 cm/s vs. 74.48 ± 8.99 cm/s, P < 0.001, Fig. 7C). There was no significant difference in the heterogeneity of the conduction velocity at different time points between the groups (Fig. 7D). Fig. 7DEX slows the myocardial conduction velocity. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of conduction velocity in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Statistical comparison of the conduction velocity at different time points in the two groups of mice. (D) Conduction velocity heterogeneity. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001). DEX slows the myocardial conduction velocity. (A) Mouse Langendorff perfused heart. Schematic representation of the rapid pacing region and the optically labeled region. (B) Examples of representative heatmaps of conduction velocity in two groups of mice paced with ventricular electrical stimulation (pacing cycle length (PCL) 100 ms). (C) Statistical comparison of the conduction velocity at different time points in the two groups of mice. (D) Conduction velocity heterogeneity. (n = 10. *P < 0.05, **P < 0.01, ***P < 0.001). Discussion This study revealed that DEX preconditioning significantly reduced the incidence of stress-induced ventricular arrhythmias in mice. DEX induced notable electrophysiological changes, including prolongation of action potential duration, extension of calcium transient duration, and a reduction in the severity of calcium transient alternans. Further details are discussed below. Catecholamines are classic drugs often used in models of induced arrhythmias, mimicking, for example, sympathetic excitation in response to stressful stimuli11–13. In the present study, the incidence of ventricular arrhythmias was significantly greater in ISO-stimulated mice than in control mice, suggesting that a strong stress response can lead to an increased risk of ventricular arrhythmias in mice. DEX has sympathoinhibitory and parasympathoexcitatory effects and reduces plasma catecholamine levels14,15. This property has led to its reported role in reducing postoperative arrhythmias during perioperative use in surgery, especially cardiothoracic surgery16,17. Our results also confirm that DEX has an antiarrhythmic effect and is beneficial for perioperative anesthesia. We found that the incidence of ISO-induced ventricular arrhythmias in mice was significantly reduced after DEX preconditioning, which is consistent with the literature. Optical mapping is a crucial technique in cardiac electrophysiological studies, as it visualizes and dynamically displays the kinetic changes in electrical conduction and calcium handling throughout the heart. This method plays a significant role in advancing our understanding of cardiac electrophysiology and the mechanisms underlying arrhythmogenesis18,19. In contrast to single-cell level calcium transient studies, optical mapping allows for the observation of calcium transients at the level of the whole heart, which is its primary advantage. The effects of ISO-simulated acute stress on the time course of myocardial epicardial action potentials in mice were observed with optical labeling techniques. Our results indicate that acute stress significantly decreases APD50 and APD80, but DEX prolongs the duration of action potentials. Zhang Wenjie et al20. utilized the whole-cell membrane clamp technique to record APD90 in rat ventricular myocytes and reported that DEX prolonged APD90. Additionally, DEX dose-dependently prolonged the growth of ventricular-like human induced pluripotent stem cell-derived cardiac myocytes (iPSC-CMs) with APD9021. Our findings are consistent with those of previous studies, as we also observed that DEX prolonged the action potential duration and mitigated the shortening of the action potential duration caused by acute stress. This observation is also consistent with the DEX-induced reduction in heart rate noted in our in vivo experimental data. This role of DEX in prolonging the cardiomyocyte action potential time course may be significant in eliminating refractory excitation in tachyarrhythmias. Furthermore, shortening the action potential duration, reducing the effective period of inactivity, and increasing spatial heterogeneity increase the risk of arrhythmias22. Our analysis of APD80 discretization indicates that DEX reduces this risk. Reducing the dispersion of cardiac repolarization may be related to the antiarrhythmic effect of DEX. Studies have revealed that DEX treatment also reduces the spatial dispersion of cardiac repolarization and suppresses tip-twisting ventricular tachycardia in the erythromycin-induced long QT syndrome-2 (LQT2) model23. Ca2+plays a crucial role in cardiac excitation-contraction coupling and is recognized as a significant signal transduction molecule. It is essential for maintaining the normal structural and electrophysiological functions of the heart. Under pathological conditions, such as stress, inflammation, and mitochondrial dysfunction, intracellular calcium regulation may become impaired, resulting in an imbalance in calcium homeostasis. This imbalance can lead to afterdepolarizations, including early afterdepolarizations and delayed afterdepolarizations, which ultimately contribute to ectopic activation, reentry formation, and arrhythmogenesis8,9. In our study, we observed that treatment with catecholamines, simulating stress resulted in a significant decrease in the time to peak calcium transients (TTP). The shorter TTP suggests that the rate of calcium release from the sarcoplasmic reticulum (SR) is increased due to aberrant RyR2 activity24; however, this rapid release of calcium is associated with the production of delayed afterdepolarizations (DAD)25. In contrast, DEX pretreatment prolonged TTP, indicating that DEX may have alleviated the aberrant activation of RyR2 and slowed the rate of calcium release from SR. Additionally, we observed that DEX prolonged calcium transient duration (CaTD), which is primarily associated with SERCA-mediated calcium uptake24. Therefore, we hypothesize that DEX may mitigate the occurrence of cytosolic calcium overload by influencing both the release and uptake of calcium mediated by the SR and SERCA, thereby reducing the probability of DAD. This mechanism likely explains why DEX is capable of combating arrhythmias. The presence of cardiac alternans, which includes action potential time‒distance (APD) alternans and intracellular calcium transient amplitude alternans, is a preliminary indication of arrhythmogenesis. Cardiac alternans can be induced by rapid pacing and becomes noticeable as the pacing cycle length gradually decreases. While current studies are still lacking concerning the initiators of APD alternans and calcium transient alternans26,27, the prevailing view suggests that calcium transient alternans play a significant role in the development of APD alternans28–30. In our experiments, we observed that the severity of calcium transient alternans alternated gradually as the pacing cycle length decreased to 60 ~ 80 ms. Utilizing optical mapping technology, our study demonstrated that action potential alternans were not observed in cases when calcium alternans were evident. This finding supports the hypothesis that calcium alternans may serve as a precursor to action potential alternans and play a pivotal role in the initiation of arrhythmias. As the stimulation frequency increases, the regulation of calcium by RyR2 and SERCA becomes increasingly unbalanced, which aligns with previous findings31–33. However, the severity of calcium transient alternans was significantly reduced after the administration of DEX. These findings further support the protective effect of DEX on intracellular calcium homeostasis may by regulating the release and recycling of Ca2+in the sarcoplasmic reticulum. After administering stress treatments, we observed that as the pacing cycle length decreased to 60 ms, the calcium transient alternans became spatially inconsistent, resulting in the emergence of spatially discordant alternans (SDA). This alternating occurrence of spatial inhomogeneities leads to heterogeneous repolarization, thereby increasing susceptibility to triggered and refractory arrhythmias34. In our study, the occurrence of spatial inhomogeneity alternations in the group receiving DEX tended to decrease compared with that in the control group, although this difference was not statistically significant. To further validate these findings, we may use RyR2 agonists or calcium antagonists to explore the specific mechanisms by which DEX affects calcium alternans. The analysis of conduction velocity indicated that DEX slow down myocardial conduction. In clinical practice, DEX has been associated with bradycardia and atrioventricular block. Research has shown that continuous use of DEX during electrophysiologic examinations in children can prolong the Wenckebach cycle length and the P-R interval35. Our experimental findings align with these previous results, indicating that DEX may lead to a reduction in conduction velocity by inhibiting atrioventricular (AV) node function. The present study has several limitations that should be acknowledged. First, while rodents are commonly used in cardiac electrophysiologic research, they may not be the best animal model for studying this field. Second, mice that were administered isoproterenol to simulate stress did not display spontaneous ventricular arrhythmias either in vivo or ex vivo. Hence, this model does not completely replicate the perioperative stress-related ventricular arrhythmias observed in humans. Third, owing to limitations in time and resources, we did not investigate the molecular mechanisms involved. Further exploration to determine the role of key signaling pathways associated with calcium regulation in the inhibition of arrhythmogenesis by DEX is warranted. The findings of this investigation improve our understanding of the mechanisms underlying the antiarrhythmic effects of DEX. Conclusion DEX preconditioning can reduce the incidence of ventricular arrhythmias induced by acute stress simulated by isoproterenol. DEX preconditioning can prolong the APD, CaTD and TTP; slow the conduction velocity; and reduce calcium transient alternation. The mechanism by which DEX potentially mitigates the occurrence of stress-related ventricular arrhythmias could be attributed to its role in preserving the balance of intracellular calcium levels. Furthermore, the continuous infusion of DEX in patients prior to surgery may be beneficial in reducing the incidence of perioperative stress-induced ventricular arrhythmias, thereby increasing the safety of anesthesia and surgical procedures. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1